Resolution relies on a specific snapshot of a third-party platform (lmarena.ai) with specific settings (Style Control On). The ultimate tiebreaker being the alphabetical order of the company name is a unique detail to note.

While tracking AI model leaderboards is common in the tech industry, specifically predicting the '#3' spot rather than the top spot is somewhat niche and specific.

All options are priced at 49.5%, implying an equal and mathematically impossible combined probability (over 700%) for each company to finish third. This fundamentally conflicts with the AI industry consensus, which acknowledges a massive capability gap between frontier labs (OpenAI, Anthropic, Google) and the rest of the field.

Predicting the exact #2 app on a specific day carries a degree of novelty and randomness. The general public usually does not track specific rankings on a specific date, though it's a standard metric for marketers, making it a moderately niche market.

May 2, 2026 - May 3, 2026: Prices for Meta AI, Netflix, Google, and Freecash surged from under 10c to over 30c-40c, due to massive speculative capital flowing in as real-time chart fluctuations intensify near the resolution date. May 2, 2026 - May 3, 2026: Claude's price dropped from a peak of 87.5c to 66.5c, as its leading position was challenged by other surging apps. May 2, 2026 - May 3, 2026: TurboTax's price plummeted from 18.1c to 0.65c, caused by a steep drop in downloads as the tax season effect faded.

The FDA's decision on the new indication for Enhertu (neoadjuvant treatment of HER2-positive breast cancer) will directly impact the valuation and short-term stock prices of AstraZeneca (AZN) and Daiichi Sankyo (4568.T). A surprise rejection or approval could trigger noticeable tradable movements for both partnered companies.

This event directly determines the label expansion for Argenx's (ARGX) flagship product, Vyvgart. An unexpected rejection (Complete Response Letter) would severely impact future revenue projections, likely causing a massive double-digit swing in the stock. Thus, this market serves as a direct event-driven hedge for ARGX equity.

Amazon's capex directly impacts its own valuation and free cash flow (AMZN). Furthermore, since a large portion of incremental spending is likely directed toward AWS data centers and AI chips, this will also have a significant material impact on suppliers like Nvidia (NVDA). As a core constituent, this data could also cause moderate volatility in the Nasdaq 100 index.

There is a severe divergence between market pricing and official corporate guidance. Amazon's management recently publicized a Capex guidance of approximately $200 billion for 2026. However, the prediction market prices the probability of Capex exceeding $170B and $180B at less than 50%. This suggests a massive market inefficiency or mispricing, likely driven by low liquidity or failure to price in the latest earnings guidance materials.

The rules explicitly state that merely leaving the launch pad (liftoff) constitutes a 'Yes', and any subsequent explosion or failed ascent does not alter the outcome. This poses a trap for casual traders who might equate 'launch' with a successful mission.

This event is directly tied to the core fundamentals of Rocket Lab (NASDAQ: RKLB). The Neutron rocket is a crucial product for the company's future revenue growth and its ability to compete with SpaceX. Confirmation of an on-time launch or a delay will have a significant and direct impact on RKLB's stock price (easily triggering a >15% move).

The market prices the probability of a 2026 launch at 48%, essentially a coin toss. However, given the recent testing anomaly in January 2026 and the subsequent official delay to 'no earlier than Q4 2026', space industry consensus and historical trends strongly point to a slip into 2027. The market is overly optimistic and is not sufficiently pricing in the historical inevitability of delays for Q4 inaugural flights following hardware failures.